Description: Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Home Page: www.aspenpharma.com
Aspen Place
Durban,
South Africa
Phone:
27 31 580 8600
Officers
| Name | Title |
|---|---|
| Mr. Stephen Bradley Saad | Group CEO & Exec. Director |
| Mr. Sean M. Capazorio | Group CFO & Exec. Director |
| Ms. Lorraine Hill | Group Chief Operations Officer & Responsible Pharmacist |
| Mr. Michael Guy Attridge B.Com., BCom, CA(SA) | Group Chief Advisor |
| Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA | Group Chief Corp. Services Officer |
| Ms. Zizipho Mmango | Group Chief Strategic Devel. Officer |
| Mr. Riaan Verster ACIS, BProc, L.L.B., L.L.M., LLB, LLM | Company Sec., Group Governance Officer & Group Compliance Officer |
| Mr. Trevor Julian Ziman | Regional Chief Exec. Officer of Asia Pacific |
| Mr. Stavros Nicolaou | Group Sr. Exec. of Strategic Trade |
| Mr. Carnie van der Linde | Group Commercial Head |
Exchange: JSE
Country: ZA : South Africa
Currency: South African Rand cents (R)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 9.8621 |
| Price-to-Book MRQ: | 0.884 |
| Price-to-Sales TTM: | 1.6025 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 8580 |